Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

March 10, 2026 07:00 ET | Source: Opus Genetics, Inc.

Opus Genetics Announces Financial Results for Full Year 2025 and Provides Corporate Update

Opus Genetics Announces Financial Results for Full Year 2025 and Provides Corporate Update
March 03, 2026 08:00 ET | Source: Opus Genetics, Inc.

Opus Genetics to Present at Upcoming Investor Conferences in March 2026

Opus Genetics to Present at Upcoming Investor Conferences in March 2026
February 27, 2026 10:10 ET | Source: Opus Genetics, Inc.

Opus Genetics Announces Initial Clinical Data from Phase 1/2 OPGx-BEST1 Gene Therapy Study at the Macula Society Annual Meeting

Opus Genetics Announces Initial Clinical Data from Phase 1/2 OPGx-BEST1 Gene Therapy Study at the Macula Society Annual Meeting
February 25, 2026 06:59 ET | Source: Opus Genetics, Inc.

Opus Genetics Announces FDA Acceptance of Supplemental New Drug Application for Phentolamine Ophthalmic Solution 0.75% for the Treatment of Presbyopia

Opus Genetics Announces FDA Acceptance of Supplemental New Drug Application for Phentolamine Ophthalmic Solution 0.75% for the Treatment of Presbyopia
February 13, 2026 07:30 ET | Source: Opus Genetics, Inc.

Opus Genetics Announces $25 Million Private Placement

Opus Genetics Announces $25 Million Private Placement
February 02, 2026 08:00 ET | Source: Opus Genetics, Inc.

Opus Genetics to Participate in Upcoming Medical and Industry Conferences in February 2026

Opus Genetics to Participate in Upcoming Medical and Industry Conferences in February 2026
January 27, 2026 07:00 ET | Source: Opus Genetics, Inc.

Opus Genetics Launches Gene Therapy Clinical Trial for MERTK-related Retinitis Pigmentosa

Opus Genetics Launches Gene Therapy Clinical Trial for MERTK-related Retinitis Pigmentosa
January 08, 2026 07:00 ET | Source: Opus Genetics, Inc.

Opus Genetics Highlights 2025 Progress and Upcoming 2026 Catalysts

Opus Genetics Highlights 2025 Progress and Upcoming 2026 Catalysts
December 16, 2025 16:01 ET | Source: Opus Genetics, Inc.

Opus Genetics Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

Opus Genetics Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
December 11, 2025 07:00 ET | Source: Opus Genetics, Inc.

Opus Genetics to Present at the J.P. Morgan 2026 Healthcare Conference

Opus Genetics to Present at the J.P. Morgan 2026 Healthcare Conference